July 1, 2020 -- Real estate developer MRA Group is building lab spaces in Philadelphia to meet the region's growing demand for cell and gene therapy.
Prospective life science companies have been attracted to the area since Philadelphia was recognized as a "Big4Bio" region but have been disappointed by the lack of available lab space, according to MRA.
The group has already added AnPac Bio, an international biotechnology company, to the space. Exegenesis Bio, a gene therapy company including its Jefferson Institute for Bioprocessing, will be moving in later this summer.
The developer hopes to complete two specialized multitenant life science lab buildings, totaling about 140,000 sq ft, in Philadelphia and one of its nearby suburbs by the end of the year. Space can be leased now.